The Stroke Report is a research initiative that focuses on the use of anticoagulant therapy in the clinical management of persons with AF. Unfortunately, data in The Stroke Report indicates that many patients who could benefit from anticoagulant therapy are not receiving it.
Targeted Drug Combination Reveals New Activity in Brain Tumors
December 28th 2021A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.
2 Clarke Drive
Cranbury, NJ 08512